Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Detalles Bibliográficos
Autores principales: Zingone, Fabiana, Buda, Andrea, Savarino, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020
Materias:
Correspondence`
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547636/
https://www.ncbi.nlm.nih.gov/pubmed/33051162
http://dx.doi.org/10.1016/j.dld.2020.09.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547636/
https://www.ncbi.nlm.nih.gov/pubmed/33051162
http://dx.doi.org/10.1016/j.dld.2020.09.020

Ejemplares similares